News Headlines Article

Talon Therapeutics wins approval for leukemia drug
San Francisco Business Times

The generally accepted notion in the drug-development space is that it takes $1 billion or more and 10-plus years to bring a therapeutic to market. Then there’s Talon Therapeutics Inc. The San Mateo company (OTCBB: TLON) won accelerated approval Thursday from the Food and Drug Administration regarding its cancer-fighting drug Marqibo.